Results 181 to 190 of about 65,434 (235)

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Tunisia: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. [PDF]

J Antimicrob Chemother
Torumkuney D, Slim L, Hammami A, Hawser S, Manenzhe R, Manoharan A.   +5 more
europepmc   +1 more source

Alemtuzumab Induction in Septuagenarians Undergoing Deceased Donor Kidney Transplantation

Clinical Transplantation, Volume 40, Issue 3, March 2026.
ABSTRACT Introduction The anti‐CD52 monoclonal antibody alemtuzumab is used as an induction agent in kidney transplantation (KT) but remains understudied in septuagenarian recipients. The study purpose was to analyze the safety and efficacy of single‐dose alemtuzumab induction in septuagenarian deceased donor (DD) KT recipients.
David I. Harriman, Alex Ng, Alan C. Farney, Giuseppe Orlando, Colleen Jay, Amber Reeves‐Daniel, Robert J. Stratta   +6 more
wiley   +1 more source

Prioritizing cefuroxime as empirical treatment in acute bacterial prostatitis: patient characteristics and outcome. [PDF]

JAC Antimicrob Resist
Lecomte E, Arys M, Christiaens A, Doyen L, Marot JC, Verbelen V, Wieërs G.   +6 more
europepmc   +1 more source

Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies

European Journal of Haematology, Volume 116, Issue 3, Page 204-214, March 2026.
ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Türkiye: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. [PDF]

J Antimicrob Chemother
Torumkuney D, Keles N, Hasdemir U, Hazırolan G, Aydemir S, Aktas Z, Oncul O, Morrissey I, Manoharan A.   +8 more
europepmc   +1 more source

Biphasic dysglycemia induced by pentamidine and detected by intermittently scanned continuous glucose monitoring: a case report of a possible drug-drug interaction with clopidogrel and literature review. [PDF]

J Pharm Health Care Sci
Nakano Y, Kuhara N, Sogawa R, Yasukochi H, Okayama Y, Motoya M, Ishii H, Hasuwa H, Shimanoe C.   +8 more
europepmc   +1 more source

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. [PDF]

J Antimicrob Chemother
Torumkuney D, Nizamuddin S, Morrissey I, Manenzhe R, Manoharan A.   +4 more
europepmc   +1 more source

Always Consider a Repeat Kidney Biopsy: Acute Interstitial Nephritis Soon After Membranous Nephropathy. [PDF]

Case Rep Nephrol
Hopkins J, Nolan J, Ladhani M, Lee C.
europepmc   +1 more source

Results from the Survey of Antibiotic Resistance (SOAR) 2018-21 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. [PDF]

J Antimicrob Chemother
Torumkuney D, Bratus E, Yuvko O, Pertseva T, Morrissey I, Beltrame CO, Manoharan A.   +6 more
europepmc   +1 more source

Impact of sulfamethoxazole, trimethoprim, diclofenac, carbamazepine, and their mixture on the metabolism of Lemna minor: a targeted metabonomic study. [PDF]

Metabolomics
Wahman R, Schröder P, Duporté G, Chiron S, Drewes J, Sauvêtre A, Cruzeiro C.   +6 more
europepmc   +1 more source